According to sources:

“He goes above and beyond when it comes to client service.”

“He has a highly reputable background.”

“He is always practical and technically savvy.”

Chambers USA 2021

Laurence J. Stein

Century City
  • 10250 Constellation Blvd.
  • Suite 1100
  • Los Angeles, CA 90067
  • USA

Larry Stein, former Global Chair of Latham & Watkins' Tax Department from 2000-2011, advises private equity firms, private and public companies, and financial institutions on transactional tax matters relating to M&A, spin-offs, offerings, and partnerships.

Mr. Stein regularly counsels clients on:

  • Mergers, acquisitions, dispositions, restructurings, and tax-free reorganizations
  • Spin-off transactions (including obtaining numerous private letter rulings from the National Office of the Internal Revenue Service)
  • Offerings of debt, equity, and other financial instruments
  • Partnerships




Mr. Stein’s representative experience includes:

  • AST & Science LLC in its business combination with New Providence Acquisition Corp., a special purpose acquisition company
  • Vivid Seats Inc. in its proposed business combination with Horizon Acquisition Corporation, a publicly-traded special purpose acquisition company
  • TechnipFMC plc in its spin-off transaction into two publicly traded companies: TechnipFMC, a fully integrated technology and services provider; and Technip Energies, a leading engineering and technology player
  • Energy Transfer LP in its US$7.2 billion acquisition of Enable Midstream Partners
  • Sony Pictures on Funimation Global Group’s US$1.175 billion acquisition of AT&T Inc.’s Crunchyroll anime business
  • Equitrans Midstream Corporation in its acquisition of EQM Midstream Partners
  • Silver Lake Partners in its US$4.7 billion sale of LLC to the Blackstone Group
  • Equitrans Midstream Corporation and EQM Midstream Partners, LP in its acquisition of 60% interest in Eureka Midstream Holdings, LLC and a 100% interest in Hornet Midstream Holdings, LLC
  • Partnership between Spectrum Equity and Definitive Healthcare, a provider of data and analytics for healthcare providers, following the equity investment by Advent International in Definitive Healthcare
  • Spectrum Equity Investors VI in the US$340 million sale of ExamSoft Worldwide to Turnitin, LLC
  • Acquisition by various funds affiliated with Spectrum Equity Management of a minority interest in DispatchTrack, a provider of a software that optimizes delivery and routes for businesses
  • Strategic Investment by Spectrum Equity in Scribd, a provider of an online subscription-based library of ebooks, audiobooks, magazines and documents
  • Merger of Energy Transfer Partners with a wholly owned subsidiary of Energy Transfer Equity
  • Spectrum Equity Investors acquisition of a majority stake in Offsec Services, a Gibraltar-based provider of information security training, ethical hacking certifications, virtual labs, and penetration testing services
  • Aon plc in its US$3.57 billion sale of Willis Towers Watson assets to Arthur J. Gallagher & Co.
  • Aon plc in US$80 billion combination with Willis Towers Watson
  • in connection with its acquisition by
  • Entercom in its acquisition of CBS Radio via a Reverse Morris Trust transaction
  • Delphi Automotive PLC in its tax-free spin-off of its Powertrain Systems segment
  • LogMeIn in its acquisition of the GoTo business of Citrix Systems, a provider of collaborative communication solutions for small businesses, via a Reverse Morris Trust transaction
  • Archrock Holdings in its spin-off of the international services and global fabrication businesses of Exterran Holdings
  • Integra LifeSciences in its tax-free spin-off of SeaSpine Holdings, a spine fusion medical device company
  • Demand Media, a worldwide digital and media company, in its tax-free spin-off of its domain services business
  • Questar Corporation, natural gas-focused energy company, in its tax-free spin-off of QEP Resources, Inc. to stockholders
  • Actavis in its US$8.5 billion acquisition of Warner-Chilcott, an Ireland-based pharmaceutical company focusing on women’s healthcare
  • Actavis in its US$28 billion acquisition of Forest Laboratories, a specialty pharmaceutical company
  • Questcor Pharmaceuticals in its US$5.6 billion sale to Mallinckrodt, an Ireland-based biopharmaceutical company
  • Cadence Pharmaceuticals, a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products, in its US$1.4 billion sale to Mallinckrodt
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.